Biomedix - Delivering a Collaborative Care Model
With the increasing adoption of telemedicine and online healthcare solutions, patient engagement is becoming more streamlined than ever before. Patients benefit from these technologies by getting better care at their homes even without visiting a hospital. However, more secure and easy-to-use solutions are still rare to find in the industry. Organizations such as Biomedix have been revolutionizing this industry with a set of innovative healthcare solutions. Since its inception, Biomedix products and services are having a positive impact on physician practices, hospitals, and health systems across the country. The company’s earlier solutions focused on one chronic condition with an eye on disease management.
The team saw that with consolidation and vertical integration, many healthcare organizations were entering into value-based care contracts, with an eye on health management. This shift required gathering even more data about their members to help navigate the risk-bearing contracts the clients were entering into and guide investments in population health. Biomedix is the market leader in front-line diagnostics for peripheral vascular disease. Their PADnet is the only diagnostic device that can support the identification of peripheral artery disease (PAD) and chronic venous insufficiency (CVI) through a unique collaborative care model.
Today, Biomedix solutions and systems are designed to securely transmit test data and patient history to a specialist for remote interpretation, saving time and eliminating the need for travel to a hospital or specialty lab for baseline testing. The company earlier also has had success in improving disease management by remotely connecting primary care and vascular sub-specialists with their point of care diagnostic devices and cloud-based communication platform. “Our latest generation of products and services are designed to expand our role to enable value-based care for organizations to manage population health by leveraging a host of diagnostic modalities that can be deployed at different point-of-care locations,” explains John Romans, CEO.
The company’s diagnostic solutions are designed to enable the screening of patient populations for a variety of chronic conditions, behavioral health issues, and assess social determinants of health. The earlier identification of these issues is key to delivering lower-cost interventions such as lifestyle modifications before they progress and become more difficult, expensive, and dangerous to treat. Their innovative and advanced mobile health assessment platform is designed to aggregate these multiple data points into a single patient record to deliver customized care solutions.
What highlights Biomedix is their innovative PADnet—a flexible and customizable vascular assessment system designed to identify hidden peripheral vascular disease through a non-invasive physiologic test in clinical settings. The solution has had a long track record of success in the Fee For Service (FFS) world, pioneering the concept of collaborative care, by enabling diagnostic studies to be performed at the point of care, and remotely interpreted by a specialist. PADnet Xpress provides the ability to screen populations in non-traditional settings like retail, health fairs, and homes with a quick, two-minute test.
Over the years, the company has been a pioneer in delivering diagnostic solutions for value-based care. Their mobile health assessment platform centralizes data for analyzing population health across multiple chronic conditions and supports a variety of diagnostic devices. “We are unique in the way that we gather the data, being the only population health management platform that features an integrated technology stack that aggregates point-of-care testing data automatically, across a variety of modalities, not only using our device, PADnet Xpress, but also a suite of best-in-class diagnostic platforms which are integrated with Biomedix Xchange,” explains Romans.
Biomedix is actively onboarding new customers in this space as well as adding new diagnostic modalities, but the big demand now is bi-directional integration. Customers want to import their entire member population into the platform so they can test their patients for risk and quality objectives. Biomedix team is well-positioned to deliver solutions that address their clients evolving needs. “Biomedix Xchange is our newest web platform that enables the ability to view chronic disease status, behavioral health issues, and SDoH factors in a single patient record, and be able to analyze the status of these over a period of time,” concludes Romans.
“Our latest generation of products and services are designed to expand our role to enable value-based care for organizations to manage population health by leveraging a host of diagnostic modalities”
BiomedixB
John Romans
Management
CEO
Website
biomedix.com
